Genome‑wide CRISPR screens in primary human T cells reveal human genes that promote or block HIV infection, uncovering potent ...

This study characterizes several novel activities of SARS-CoV-2 helicase nsp13, providing valuable insights into potentially new functions of this essential RNA-processing enzyme in the virus life ...

Researchers have developed a thin plastic film that tears apart viruses on contact, offering a promising new way to keep high ...

Researchers have developed a thin plastic film that tears apart viruses on contact, offering a promising new way to keep high ...

The FDA has granted Fast Track designation to pevifoscorvir sodium, an oral capsid assembly modulator for chronic HBV.

New research shows the common cold virus may stay hidden in the body and spread without symptoms long after recovery.

Orthogon Therapeutics today announced the closing of a follow-on $11 million financing, bringing its total capital raised to $36 million. This financing supports the continued advancement of its first ...

Aligos Therapeutics has secured a $25 million cash infusion in return for selling the China rights to its phase 2-stage ...

Eradivir Inc., a clinical-stage biotech company developing antibody-recruiting small molecules to treat disease, today announced it will deliver oral presentations at ESCMID Global 2026 and at the ...

Aligos to receive an upfront payment of $25M USDUp to $420M USD in clinical, regulatory, and sales milestones along with tiered, high ...

While it was previously thought that keratinocytes (skin cells) were only passive conductors that allow the rabies virus to ...

PBGENE-HBV is the only clinical stage program targeting the elimination of cccDNA leading to sustained loss of HBV DNA. The FDA has previously provided guidance thatsustained loss of HBV DNA is an ...